Serum MIF concentrations were statistically significantly higher in SSc patients than in HC, with detectable MIF in 99% (104/105) of SSc compared to 68.1% (32/47) of HC cohorts (Figure 1a and Supplementary table 2). This evidence concerns the gene MIF and systemic sclerosis.